An Open-Access Dataset of Thorough QT Studies Results

Barbara Wiśniowska, Zofia Tylutki and Sebastian Polak
Additional contact information
Barbara Wiśniowska: Pharmacoepidemiology and Farmacoeconomics Unit, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, str., 30-688 Krakow, Poland
Zofia Tylutki: Pharmacoepidemiology and Farmacoeconomics Unit, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, str., 30-688 Krakow, Poland
Sebastian Polak: Pharmacoepidemiology and Farmacoeconomics Unit, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, str., 30-688 Krakow, Poland

Data, 2020, vol. 5, issue 1, 1-5

Abstract: Along with the current interest in changes of cardiovascular risk assessment strategy and inclusion of in silico modelling into the applicable paradigm, the need for data has increased, both for model generation and testing. Data collection is often time-consuming but an inevitable step in the modelling process, requiring extensive literature searches and other identification of alternative resources providing complementary results. The next step, namely data extraction, can also be challenging. Here we present a collection of thorough QT/QTc (TQT) study results with detailed descriptions of study design, pharmacokinetics, and pharmacodynamic endpoints. The presented dataset provides information that can be further utilized to assess the predictive performance of different preclinical biomarkers for QT prolongation effects with the use of various modelling approaches. As the exposure levels and population description are included, the study design and characteristics of the study population can be recovered precisely in the simulation. Another possible application of the TQT dataset is the analysis of drug characteristic/QT prolongation/TdP (torsade de pointes) relationship after the integration of provided information with other databases and tools. This includes drug cardiac safety classifications (e.g., CredibleMeds), Comprehensive in vitro Proarrhythmia Assay (CiPA) compounds classification, as well as those containing information on physico-chemical properties or absorption, distribution, metabolism, excretion (ADME) data like PubChem or DrugBank.

Keywords: Thorough QT; TQT; proarrythmic potential; dataset (search for similar items in EconPapers)
JEL-codes: C8 C80 C81 C82 C83 (search for similar items in EconPapers)
Date: 2020
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/2306-5729/5/1/10/pdf (application/pdf)
https://www.mdpi.com/2306-5729/5/1/10/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jdataj:v:5:y:2020:i:1:p:10-:d:313039

Access Statistics for this article

Data is currently edited by Ms. Cecilia Yang

More articles in Data from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().